POS0052 FIVE-YEAR FOLLOW-UP OF A 2-YEAR MRI TREAT-TO-TARGET STRATEGY ON RADIOGRAPHIC DAMAGE PROGRESSION IN RHEUMATOID ARTHRITIS PATIENTS IN CLINICAL REMISSION - THE IMAGINE-MORE STUDY

Abstract

BackgroundRadiographic joint damage progresses in 20-30% of rheumatoid arthritis (RA) patients despite fulfilling clinical remission criteria [1]. Osteitis assessed on MRI predicts subsequent bone damage progression [2]. Therefore, targeting absence...